Arcellx (ACLX) Stock Jumped 25% On Friday, Why?
After announcing a strategic partnership, Arcellx Inc. (Nasdaq: ACLX) increased 27.95% to $27.74 in the current market on Friday. What step has ACLX declared? Today, Arcellx (ACLX) and Kite, a Gilead subsidiary, announced a global strategic partnership to jointly develop and market CART-ddBCMA, Arcellx’s main late-stage therapeutic candidate. For the treatment of patients with relapsed […]
